MARK W KROLL Insider Trading $HAE HAEMONETICS CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK W KROLL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK W KROLL. MARK W KROLL is Director in HAEMONETICS CORP ($HAE) and in AXON ENTERPRISE, INC. ($TASR) and Director in TASER INTERNATIONAL INC ($TASR).
MARK W KROLL in HAEMONETICS CORP
Trading Symbol: HAEIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MARK W KROLL: Director
Holdings: 20,401 shares
Current Value: $757,897
Latest Transaction: Jul 22 2020
$HAE Market Capitalization: $1.91B
$HAE Previous Close: $37.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK W KROLL in HAEMONETICS CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 22 2020 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 1,983 | 0 | 20,401 | 18.4 K to 20.4 K (+10.77 %) |
Apr 13 2020 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 45.45 | 6,573 | 298,743 | 0 | |
Apr 13 2020 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 102.00 | 4,329 | 441,558 | 18,418 | 22.7 K to 18.4 K (-19.03 %) |
Apr 13 2020 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 102.00 | 6,573 | 670,446 | 22,747 | 29.3 K to 22.7 K (-22.42 %) |
Apr 13 2020 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 45.45 | 6,573 | 298,743 | 29,320 | 22.7 K to 29.3 K (+28.90 %) |
Apr 13 2020 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 870 | 0 | 22,747 | 23.6 K to 22.7 K (-3.68 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 1,460 | 0 | 23,617 | 22.2 K to 23.6 K (+6.59 %) |
May 24 2019 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 1,449 | 0 | 22,157 | 23.6 K to 22.2 K (-6.14 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 114.00 | 10,707 | 1,220,598 | 24,748 | 35.5 K to 24.7 K (-30.20 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 36.37 | 8,196 | 298,089 | 35,455 | 27.3 K to 35.5 K (+30.07 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 200 | 0 | 27,259 | 27.5 K to 27.3 K (-0.73 %) |
Nov 09 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Gift | G | 0.00 | 1,000 | 0 | 27,459 | 28.5 K to 27.5 K (-3.51 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 1,696 | 0 | 28,459 | 26.8 K to 28.5 K (+6.34 %) |
Jan 03 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 34.41 | 7,118 | 244,895 | 0 | |
Jan 03 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 63.00 | 7,118 | 448,434 | 26,763 | 33.9 K to 26.8 K (-21.01 %) |
Jan 03 2018 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 34.41 | 7,118 | 244,895 | 33,881 | 26.8 K to 33.9 K (+26.60 %) |
Jul 31 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 39.27 | 4,329 | 170,000 | 26,763 | 22.4 K to 26.8 K (+19.30 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 27.24 | 8,580 | 233,719 | 0 | |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.56 | 307 | 12,759 | 22,434 | 22.7 K to 22.4 K (-1.35 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.55 | 400 | 16,620 | 22,741 | 23.1 K to 22.7 K (-1.73 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.55 | 100 | 4,155 | 23,141 | 23.2 K to 23.1 K (-0.43 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.54 | 273 | 11,340 | 23,241 | 23.5 K to 23.2 K (-1.16 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.53 | 129 | 5,357 | 23,514 | 23.6 K to 23.5 K (-0.55 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.52 | 818 | 33,963 | 23,643 | 24.5 K to 23.6 K (-3.34 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.51 | 276 | 11,455 | 24,461 | 24.7 K to 24.5 K (-1.12 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.50 | 453 | 18,800 | 24,737 | 25.2 K to 24.7 K (-1.80 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.50 | 100 | 4,150 | 25,190 | 25.3 K to 25.2 K (-0.40 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.49 | 100 | 4,149 | 25,290 | 25.4 K to 25.3 K (-0.39 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.49 | 300 | 12,446 | 25,390 | 25.7 K to 25.4 K (-1.17 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.48 | 1,900 | 78,812 | 25,690 | 27.6 K to 25.7 K (-6.89 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.48 | 300 | 12,443 | 27,590 | 27.9 K to 27.6 K (-1.08 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.47 | 1,771 | 73,443 | 27,890 | 29.7 K to 27.9 K (-5.97 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.47 | 300 | 12,440 | 29,661 | 30 K to 29.7 K (-1.00 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.46 | 500 | 20,730 | 29,961 | 30.5 K to 30 K (-1.64 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.46 | 100 | 4,146 | 30,461 | 30.6 K to 30.5 K (-0.33 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.45 | 53 | 2,197 | 30,561 | 30.6 K to 30.6 K (-0.17 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.45 | 200 | 8,290 | 30,614 | 30.8 K to 30.6 K (-0.65 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.45 | 100 | 4,145 | 30,814 | 30.9 K to 30.8 K (-0.32 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.44 | 100 | 4,144 | 30,914 | 31 K to 30.9 K (-0.32 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 27.24 | 8,580 | 233,719 | 31,014 | 22.4 K to 31 K (+38.25 %) |
Jul 25 2016 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 29.59 | 5,746 | 169,995 | 22,478 | 16.7 K to 22.5 K (+34.34 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 4,337 | 0 | 16,732 | 12.4 K to 16.7 K (+34.99 %) |
Mar 03 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 29.23 | 11,328 | 331,117 | 0 | |
Mar 03 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 44.80 | 11,328 | 507,483 | 12,395 | 23.7 K to 12.4 K (-47.75 %) |
Mar 03 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 29.23 | 11,328 | 331,117 | 23,723 | 12.4 K to 23.7 K (+91.39 %) |
Page: 1